-
Symbol
-
AEON on NYSE
-
Investment type
-
Equity / Class A Common Stock
-
Latest Disclosed Shares Owned
-
465,029 shares
-
Security Ownership %
-
4.1%
L1 Capital Global Opportunities Master Fund, Ltd. ownership in AEON Biopharma, Inc. Class A Common Stock (AEON)
15 May 2025 - L1 Capital Global Opportunities Master Fund, Ltd. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 465,029 shares of AEON Biopharma, Inc. Class A Common Stock (AEON).
This represents 4.1% ownership of the company.
In their previous filing dated 13 Jan 2025, L1 Capital Global Opportunities Master Fund, Ltd. had reported owning 8,960,000 shares, indicating a decrease of +95%.
.